rAAV6-mediated miR-29b delivery suppresses renal fibrosis.

Suguru SaitoShin-Ichiro OhnoYuichirou HaradaKeiki OikawaKoji FujitaShouichirou MineoAsako GondoYoshihiko KannoMasahiko Kuroda

Published in: Clinical and experimental nephrology (2019)

Our study has revealed that rAAV6 is the most suitable serotype for kidney-targeted gene delivery and rAAV6-mediated miR-29b delivery into kidney TECs can suppress established renal fibrosis.

Keyphrases

signaling pathway
cancer therapy
single cell
drug delivery
multidrug resistant